| Dr Kitrina Lou Kearfott, MD | |
|
234 Medical Cir Ste 1, Morehead, KY 40351-1194 | |
| (606) 674-6386 | |
| (606) 674-3096 |
| Full Name | Dr Kitrina Lou Kearfott |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 234 Medical Cir Ste 1, Morehead, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033256110 | NPI | - | NPPES |
| 64899461 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 260963 (New York) | Secondary |
| 207Q00000X | Family Medicine | 26900 (Kentucky) | Primary |
| Entity Name | Gim Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326411026 PECOS PAC ID: 5294036521 Enrollment ID: O20151210001753 |
News Archive
A $2.5 million federal grant will allow a multidisciplinary team at The University of Texas Health Science Center at Houston to provide prevention and treatment information about HIV, AIDS and sexually transmitted diseases to underserved individuals with substance abuse or mental disorders.
It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but scientists do not yet fully understand why it is more frequently associated with certain kinds of tumor than others, or why not all cancer patients develop it.
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, announced three poster presentations at the National Lipid Association annual meeting held in Las Vegas, Nevada, May 30- June 2, 2013, as well as a Synageva-sponsored satellite symposium held on Friday, May 31, 2013.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
The Karmanos Cancer Institute and Wayne State University School of Medicine will launch the nation's largest study of African American cancer survivors to better understand disproportionately high incidence and mortality from cancer and its impact on this specific patient population.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kitrina Lou Kearfott, MD 234 Medical Cir Ste 1, Morehead, KY 40351-1194 Ph: (606) 784-6641 | Dr Kitrina Lou Kearfott, MD 234 Medical Cir Ste 1, Morehead, KY 40351-1194 Ph: (606) 674-6386 |
News Archive
A $2.5 million federal grant will allow a multidisciplinary team at The University of Texas Health Science Center at Houston to provide prevention and treatment information about HIV, AIDS and sexually transmitted diseases to underserved individuals with substance abuse or mental disorders.
It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but scientists do not yet fully understand why it is more frequently associated with certain kinds of tumor than others, or why not all cancer patients develop it.
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, announced three poster presentations at the National Lipid Association annual meeting held in Las Vegas, Nevada, May 30- June 2, 2013, as well as a Synageva-sponsored satellite symposium held on Friday, May 31, 2013.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
The Karmanos Cancer Institute and Wayne State University School of Medicine will launch the nation's largest study of African American cancer survivors to better understand disproportionately high incidence and mortality from cancer and its impact on this specific patient population.
› Verified 8 days ago
Dr. James C Lacock, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 Medical Cir, Morehead, KY 40351 Phone: 606-784-6641 Fax: 606-780-2382 | |
Kimberly D Martin, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 Medical Circle, Morehead, KY 40351 Phone: 606-784-6641 Fax: 606-780-2373 | |
Selena G. Raines, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-783-7281 | |
Ann Colbert, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 Fax: 606-783-6904 | |
Christian F Weigel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Beacon Hill Rd Ste 201, Morehead, KY 40351 Phone: 606-780-0444 Fax: 606-784-2344 | |
Craig Burrows, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 316 W 2nd St, Morehead, KY 40351 Phone: 606-784-3771 Fax: 606-783-6847 |